US Government Marijuana Reclassification and Tilray Brands Stock Volatility
TLRY Tilray Brands Inc
$2.85 -2.40%
View chart & analysis → - 1The US government announced earlier this year that it would reclassify medical cannabis products from Schedule 1 to Schedule 3.
- 2Tilray Brands has recorded a 76% decline in its stock price over the past 12 months.
- 3Tilray, a company with a market capitalization of $421.2 million, is a Canadian producer and will not directly benefit from the reclassification.
So what's the key point?
The US government announced it will change the classification of medical cannabis. Tilray Brands is a Canadian company, so it is difficult for them to receive direct benefits from this decision.
Source The Motley Fool +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.